Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PolySciTech, a division of Akina, Inc., is a biotechnology company specializing in the development and supply of biodegradable and biocompatible polymers for controlled drug delivery and biomedical applications. The company offers an extensive catalog of research-grade materials, including PLGA, PEG, and various block copolymers, as well as specialized hydrogels and fluorescently labeled polymers. Beyond product sales, PolySciTech provides contract research services (CRO) focused on polymer synthesis, characterization, and formulation development for pharmaceutical and academic clients. Their technologies are primarily utilized in the creation of nanoparticles, microparticles, and injectable depots for the sustained release of small molecules and biologics. Based in West Lafayette, Indiana, the company supports global research efforts in oncology, ophthalmology, and regenerative medicine through its specialized biomaterials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PolySciTech.